ストックスクリーナーアプリを入手
125.77
0.55%
0.69
アフターアワーズ：
125.77
Insmed Inc (INSM) 最新ニュース
Insmed (INSM) Q2 2026 Earnings Call Transcript - AOL.com
Biotech Is Booming, But These 2 Stocks Missed the Memo - Sahm
Insmed Slides 4.3% as Recent Insider Sales and Post-Earnings Profit-Taking Weigh on Shares - Quiver Quantitative
INSM, FSLR, APTV: Dreaded Death Cross Has Formed On These Stocks — What It Means For Investors - Stocktwits
Insmed Director Melvin Sharoky Reports Sale of 5,000 Shares via Padonia, LLC - Kalkine Media
Insmed Insider Sold Shares Worth $637,650, According to a Recent SEC Filing - marketscreener.com
Insmed (NASDAQ: INSM) director sells 5,000 shares via Padonia LLC - Stock Titan
How Insmed’s Sharply Narrowed Q2 2026 Net Loss At Insmed (INSM) Has Changed Its Investment Story - simplywall.st
BMO Capital Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $192 - Moomoo
Insmed’s New Lung Disease Study Data A Win For Company, Says Analyst - stocktwits.com
Insmed (NASDAQ: INSM) holder Padonia targets $638K share sale - Stock Titan
symbol__ Stock Quote Price and Forecast - CNN
Insmed CMO Martina Flammer sells $3.49m in company stock By Investing.com - Investing.com Australia
Insmed CMO Martina Flammer sells $3.49m in company stock - Investing.com
H.C. Wainwright Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $220 - Moomoo
13,000 Shares in Insmed, Inc. $INSM Purchased by S&CO Inc. - MarketBeat
Insmed, Inc. $INSM Shares Bought by Empowered Funds LLC - MarketBeat
Insmed Stock Price Forecast. Should You Buy INSM? - StockInvest.us
Darwin Global updates Insmed Inc (INSM) ownership, reporting 3.0% beneficial stake - Stock Titan
INSM|Insmed Inc|Price:123.740|Chg%:-2.590 - TradingKey
Insmed(INSM.US) Officer Sells US$31.96 Million in Common Stock - moomoo.com
FY2026 Earnings Forecast for Insmed Issued By HC Wainwright - MarketBeat
Handelsbanken Fonder AB Grows Stake in Insmed, Inc. $INSM - MarketBeat
Insmed (NASDAQ:INSM) COO Sells 239,850 Shares - MarketBeat
Insmed Insider Sold Shares Worth $31,964,810, According to a Recent SEC Filing - marketscreener.com
Insmed Chief Operating Officer Sold Shares Worth Over $31M - TradingView
INSMED Inc (INSM) COO exercises 239,850 options and sells matching shares - Stock Titan
HC Wainwright Brokers Increase Earnings Estimates for Insmed - MarketBeat
Insmed to Host First-Quarter 2024 Financial Results Conference Call on Thursday, May 9, 2024 - kalkine.ca
Analysts Offer Insights on Healthcare Companies: Insmed (INSM), Minerva Neurosciences (NERV) and Zymeworks (ZYME) - The Globe and Mail
INSM (INSM) insider notice covers 239,850 shares and prior sales data - Stock Titan
INSM Maintained by JP Morgan -- Price Target Lowered to $175 - GuruFocus
Insmed (NASDAQ:INSM) Price Target Cut to $175.00 by Analysts at JPMorgan Chase & Co. - MarketBeat
INSM Reiterates by Truist Securities -- Price Target Raised to $195 - GuruFocus
$1000 Invested In Insmed 5 Years Ago Would Be Worth This Much Today - Benzinga
H.C. Wainwright reiterates Buy on Insmed stock, $220 target By Investing.com - Investing.com Australia
H.C. Wainwright reiterates Buy on Insmed stock, $220 target - Investing.com India
High Growth Tech Stocks in the US to Watch - simplywall.st
Pacer Advisors Inc. Has $1.19 Million Holdings in Insmed, Inc. $INSM - MarketBeat
Assenagon Asset Management S.A. Acquires 155,011 Shares of Insmed, Inc. $INSM - MarketBeat
Insmed Inc (INSM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Insmed (NASDAQ:INSM) Posts Earnings Results - MarketBeat
Insmed (INSM) Stock Cools As BRINSUPRI Surge Recasts Growth Profile - simplywall.st
Insmed Insider Sold Shares Worth $3,494,838, According to a Recent SEC Filing - marketscreener.com
INSM Maintained by Guggenheim -- Price Target Lowered to $205 - GuruFocus
Insmed slips as investors digest a sharp post-earnings rally - Quiver Quantitative
INSM Maintained by Wells Fargo -- Price Target Raised to $169 - GuruFocus
Insmed Outlook Strengthens After Q2 Results, RBC Says - Yahoo Finance
What Insmed Stock’s Premium Is Actually Buying - Trefis
INSM Maintained by Evercore ISI Group -- Price Target Raised to $170 - GuruFocus
Has Insmed (INSM) Risen Above Fair Value After Its 3 Year Run? - Yahoo Finance
Insmed Tops Q2 Earnings Estimates, Stock Soars 34% on Brinsupri Uptake - Zacks Investment Research
Insmed Stock: Is a Historic Drug Launch a Clear Buy Signal? - Trefis
Insmed Incorporated Q2 2026 Earnings Call Summary - Yahoo Finance
INSM SWOT Analysis: Financial Strengths and Challenges Revealed in 10-Q Filing - GuruFocus
Quantinno Capital Management LP Grows Stock Holdings in Insmed, Inc. $INSM - MarketBeat
Insmed (INSM) Is Up 30.6% After Steeply Narrowing Losses And Raising 2026 Revenue Guidance – What’s Changed - Yahoo Finance
Insmed (INSM) Soars 33.86% as Brinsupri Drives Fourfold Growth. Here’s What to Watch Next - Yahoo Finance
1.21%
1.07%
大文字化:
|
ボリューム (24 時間):